4
Tetrahedron
Chem., 1958, 23, 1230; Feuer, H.; Brown, F. J. Org. Chem., 1970, 35,
1468; (c) Mellor', J. M.; Smith, N. M. J. Chem. Soc., Perkin Trans 1,
1984, 2927; Denmark, S. E.; Nicaise, O.; Edwards, J. P. J. Org. Chem.
1990, 55, 6219; (d) Friestad, G. K.; Ding, H. Angew. Chem., Int. Ed.
2001, 40, 4491; Ding, H.; Frestad, G. K. Org. Lett. 2004, 6, 637; (e)
Fernández, R.; Ferrete, A.; Lassaletta, J. M.; Llera, J. M.; Monge, A.
Angew. Chem., Int. Ed. 2000, 39, 2893; (f) Chandrasekhar, S.; Reddy,
C. R.; Rao, J. R. Synlett, 2001, 10, 1561.
5
(a) Juhl, K.; Jørgensen, K. A. J. Am. Chem. Soc. 2002, 124, 2420; (b)
Juhl, K..; Gathergood, N.; Jørgensen, K. A. Angew. Chem., Int. Ed.
2001, 40, 2995; (c) List, B. Tetrahedron 2002, 58, 5573; (d) List, B. J.
Am. Chem. Soc. 2002, 124, 5656; (e) Kotkar, S. P.; Chavan, V. B.;
Sudalai, A. Org. Lett. 2007, 9, 1001; (f) Lim, A.; Choi, J. H.; Tae, J.
Tetrahedron Lett., 2008, 49, 4882; (g) Ahuja, B. B.; Sudalai, A. RSC.
Advances, 2015, 5, 21803.
Scheme 2 Formal synthesis of anti-diabetic drug, (R)-sitagliptin
6
(a) Kotkar, S. P.; Sudalai, A. Tetrahedron Lett., 2006, 47, 6813; (b)
Talluri, S. K.; Sudalai, A. Tetrahedron, 2007, 63, 9758; (c)
Chouthaiwale, P. V.; Kotkar, S. P.; Sudalai, A. Arkivoc, 2009, 88; (d)
Rawat, V.; Chouthaiwale, P. V.; Chavan, V. B.; Suryavanshi G.;
Sudalai, A. Tetrahedron Lett., 2010, 51, 6565.
Conclusions
In conclusion, we have demonstrated an efficient,
environmentally benign approach to cleave N-N bonds in
7
Lawrence, N. J.; Drew, M. D.; Bushell, S. M. J. Chem. Soc., Perkin
Trans. 1, 1999, 3381.
8
9
Rahaim, Jr., R. J.; Maleczka, Jr. R. E. Org. Lett. 2005, 7, 5087.
(a) Jankovic, J. J. Neurol. Neurosurg. Psychiatry 2008, 79, 368; (b)
King, L. A. Drug Testing Anal. 2014, 6, 808; (c) Thornberry, N. A.;
Weber, A. E. Curr. Top. Med. Chem. 2007, 7, 557; (d) Aschner, P.;
Kipnes, M. S.; Lunceford, J. K.; Sanchez, M.; Mickel C.; Herman, D.
E. W. Diabetes Care, 2006, 29, 2632.
dibenzyl-1-alkylhydrazine-1,2-dicarboxylate to furnish N-
(tert-butoxy)carbamates. The method effectively cleaves N-
N bond in a variety of hydrazine compounds containing a
number of different functional group to their respective
amines, which can be used as building blocks in medicinal
chemistry. The use of polymethylhydrosiloxane (PMHS), an
inexpensive, easy to handle, environmental benign reagent
as reducing agent in our protocol makes it more viable than
other reported methods.
10
(a) Kunai, A.; Sakurai, T.; Toyoda, E. ; Ishikawa, M.; Yamamoto, Y.
Organometallics, 1994, 13, 3233; (b) Ferreri, C.; Costantino,C.;
Chatgilialoglu, C.; Boukherroub, R.; Manuel, G. J. Organomet. Chem.,
1998, 554, 135; (c) Chouthaiwale, P. V.; Rawat V.; Sudalai, A.
Tetrahdron Lett., 2012, 53, 148.
11 Dey, S.; Sudalai, A. Tetrahedron: Asymmetry, 2015, 26, 67.
12
Dictionary of Organic Compounds, 5th ed.; Chapman and Hall: New
York, NY, 1982; Vol. 1.
Acknowledgements
13 Victoria, M. Lett. Org. Chem., 2010, 7, 159.
14 Hale, K. J.; Delissar, V. M.; Manaviazar, S. Tetrahedron Lett., 1992, 33,
7613.
SD, BBA & SKG thank CSIR, New Delhi for the award of senior
research fellowships and CSIR, Indus MAGIC (CSC 0123) and
DST, (No. SR/S1/OC-42/2014) New Delhi for financial support.
The authors are also thankful to Dr. V.V. Ranade, Chair, Chem.
Engg. & Process Develop. for his constant encouragement.
15 Gommermann, N.; Knochel, P. Tetrahedron, 2005, 61, 11418.
Supplementary Material
Supplementary data (1H and 13C NMR spectra for all
compounds, detailed experimental procedures) associated with
this article can be found, in the online version.
References and Notes
1
(a) Karsten, E.; Erhard, H.; Roland, R.; Hartmut, H. Amines,
Aliphatic. Ullmann's Encyclopedia of Industrial Chemistry,
2000; (b) Simplício, A.; Clancy, J. M.; Gilmer, J. F. Molecules,
2008, 13, 519.
2
(a) Thornberry, N. A.; Weber, A. E. Curr. Top. Med. Chem., 2007, 7,
557; (b) King, L. A. Drug Testing and Analysis, 2014, 6, 808;
Veldkamp, W.; Tazelaar, A. P.; Freyburger, W. A.; Keasling, H. H.
Toxicol. Appl. Pharmacol., 1964, 6, 15; (c) Jankovic, J. J. Neurol.
Neurosurg. Psychiatr. 2008, 79, 368; Berchtold, N. C.; Cotman, C. W.
Neurobiol. Aging, 1998, 19, 173; Prada, M. D.; Kettler, R.; Keller, H.
H.; Cesura, A. M.; Richards, J. G.; Marti, J.; Muggli-Maniglio, D.;
Wyss, P. C.; Kyburz, E.; Imhof, R. J. Neural. Transm. Suppl., 1990,
29, 279; (d) Jimenez, A.; Vazquez, D. In Antibiotics; F. E. Hahn, Ed.;
Springer: Berlin, 1979; pp 1– 19; Grollmann, A. P. J. Biol. Chem.
1967, 242, 3226; Frye, W. W.; Mule, J. G.; Swartzwelder, C. Antibiot.
Ann. 1955, 820.
3
(a) Patai, S. The Chemistry of the Amino Group, Vol. 4; Ed.;
Interscience: London, 1968; (b) S. Patai, The Chemistry of the Azido
Group,
Vol.
11;
Ed.;
Interscience:
London,
1971;
(c) Patai, S. The Chemistry of the Hydrazo, Azo and Azoxy Groups,
Part 1 & 2; Ed.; Wiley: London, 1975.
4
(a) Stetter , H.; Spangenberger, H. Chem. Ber., 1958, 91, 1982; Nelsen,
S. F.; Willi, M. R. J. Org. Chem., 1984, 49, 1; (b) Graefe, A. F. J. Org.